In fact, in del(5q) MDS patients responding to Lenalidomide, PLCβ1 expression is specifically increased only in the cytoplasm of the del(5q) cells, whereas, in the same subpopulation, PKCα translocates to the nucleus [59]. This evidence concerns the gene PLCB1 and myelodysplastic syndrome.